News
Insights
Jobs
Career Advice
Companies
Hotbeds
More

SUBSCRIBE

SUBSCRIBE

News
Insights
Jobs
Career Advice
Companies
Hotbeds
More

Search Query

Cegedim: Consolidated Turnover - 1st Semester 2004

October 19, 2005 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Consolidated turnover is up 11.3% over the first semester 2004.

Twitter
LinkedIn
Facebook
Email
Print

LATEST

Drug pricing

10 Best-Selling Drugs of 2024 Rake in Billions Amid Exclusivity Threats

March 5, 2025
·
11 min read
·
Tristan Manalac
Rare diseases

Rare Disease Biotechs Left in a Lurch as Congress Fails To Renew Priority Review Program

March 5, 2025
·
9 min read
·
Annalee Armstrong
Layoffs

Atara Halves Workforce Again, Pauses 2 CAR T Programs

March 4, 2025
·
2 min read
·
Angela Gabriel
Cancer

BeiGene Gets Yet Another Label Expansion for PD-1 Drug Tevimbra

March 4, 2025
·
2 min read
·
Dan Samorodnitsky
Approvals

Roche Continues Regulatory Run With Acute Stroke Expansion for Heart Attack Drug

March 4, 2025
·
2 min read
·
Tristan Manalac

FEATURED STORIES

Drug Development

The Chilling Effect: State Actions, Patient Data Vulnerability, and DEI Uncertainty

March 3, 2025
·
1 min read
Cancer

The Search for the Next Keytruda: Immuno-Oncology’s Next Play

March 3, 2025
·
7 min read
·
Heather McKenzie
Obesity

FDA, Other Experts Seek to Redefine Obesity and Prioritize Maintenance Treatment

March 3, 2025
·
7 min read
·
Kate Goodwin
Drug Development

Building Patient Trust Amid an Environment of Distrust

February 28, 2025
·
1 min read
·
Lori Ellis
Rare diseases

6 Rare Diseases That Have New FDA-Approved Treatments

February 28, 2025
·
7 min read
·
Shawna Williams

BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.

Explore
About
More

© 1985 - 2025 BioSpace.com. All rights reserved.

twitter
instagram
facebook
linkedin